OM (OM) Stock Price & Analysis
OM (OM) rose 0.00% to USD 4.04 as of July 25, 2026 at 03:45 UTC, according to Nexqual real-time market data.
OM last closed at USD 4.04; the session ranged USD 4.03–4.35 on volume of 88,946 shares. Market capitalization is —, with a 52-week range of USD 3–18.63 (NMS). Source: Nexqual, July 25, 2026 at 03:45 UTC.
Key Statistics (as of July 25, 2026 at 03:45 UTC)
| Price | USD 4.04 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 4.04 |
| Open | USD 4.04 |
| Day Range | USD 4.03 – 4.35 |
| 52-Week Range | USD 3 – 18.63 |
| Volume | 88,946 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (OM)
Nexqual's technical model rates OM "SELL" based on 1 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 03:45 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 42.45 (neutral) |
| vs SMA50 | Below (USD 4.44) |
| MACD | -0.11 (negative) |
From OM's Latest SEC 10-K Filing (filed 2026-02-13)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| LUNG | Pulmonx Corporation | USD 1.17 | ▼ 3.31% |
| LOB | Live Oak Bancshares, Inc. | USD 42.08 | ▲ 2.51% |
| FTHM | Fathom Holdings Inc. | USD 0.85 | ▼ 2.3% |
| DCBO | Docebo Inc. | USD 19.37 | ▼ 0.87% |
| PRLD | Prelude Therapeutics Incorporat | USD 3.83 | ▼ 2.42% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 03:45 UTC. This page is informational and not investment advice.